# Kunming Aoqun Bio-Tech Co,. Ltd · 66-41 · CHINA — FDA import alert red lists: firms subject to detention without physical examination

For Kunming Aoqun Bio-Tech Co,. Ltd · 66-41 · CHINA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is CHINA; product is Muscle Ease dietary supplement | Muscle Ease dietary supplement; product code is 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 11/27/2024; address is Kunming National High & New Room 2nd , Floor;209 2188 No. Kegao Road , Kunming, Yunnan CHINA, verified against its source on 2026-09-16.

- **Firm:** Kunming Aoqun Bio-Tech Co,. Ltd _(verified: appears in the quote below)_
- **Import alert:** 66-41
- **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- **Country:** CHINA _(verified: appears in the quote below)_
- **Address:** Kunming National High & New Room 2nd , Floor;209 2188 No. Kegao Road , Kunming, Yunnan CHINA _(verified: appears in the quote below)_
- **Date published:** 11/27/2024 _(verified: appears in the quote below)_
- **Product code:** 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. _(verified: each item appears in the quote below)_
- **Product:** Muscle Ease dietary supplement | Muscle Ease dietary supplement _(verified: each item appears in the quote below)_
- **FDA notes:** The product is not generally recognized as safe and effective for the described uses and therefore, the product is a "new drug” under section 201(p) of the Act [21 U.S.C. § 321(p)]. New drugs may not be legally marketed in the U.S. without prior approval from the FDA as described in section 505(a) of the Act [21 U.S.C. § 355(a)]. | The product is not generally recognized as safe and effective for the described uses and therefore, the product is a "new drug” under section 201(p) of the Act [21 U.S.C. § 321(p)]. New drugs may not be legally marketed in the U.S. without prior approval from the FDA as described in section 505(a) of the Act [21 U.S.C. § 355(a)]. _(verified: each item appears in the quote below)_

## What the source says

> Kunming Aoqun Bio-Tech Co,. Ltd Date Published : 11/27/2024 Kunming National High & New Room 2nd , Floor;209 2188 No. Kegao Road , Kunming, Yunnan CHINA 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 11/27/2024 Desc: Muscle Ease dietary supplement Notes: The product is not generally recognized as safe and effective for the described uses and therefore, the product is a "new drug” under section 201(p) of the Act [21 U.S.C. § 321(p)]. New drugs may not be legally marketed in the U.S. without prior approval from the FDA as described in section 505(a) of the Act [21 U.S.C. § 355(a)]. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 11/27/2024 Desc: Muscle Ease dietary supplement Notes: The product is not generally recognized as safe and effective for the described uses and therefore, the product is a "new drug” under section 201(p) of the Act [21 U.S.C. § 321(p)]. New drugs may not be legally marketed in the U.S. without prior approval from the FDA as described in section 505(a) of the Act [21 U.S.C. § 355(a)].

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).